Found 290 matching trials
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients PHASE2 The goal of this clinical research study is to learn if temozolomide alone ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation PHASE2 The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016) PHASE2 The study evaluates safety and efficacy of vaniprevir (MK7009), when admini...
Show More Location
Multiple Locations
Learn More & Join Trial
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B EARLY_PHASE1 Previous studies have shown that there are alterations in the number and af...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC PHASE1 The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Show More Location
Baylor College of Medicine - Methodist Hospital
Learn More & Join Trial
Boceprevir Treatment in Liver Pre-transplant HCV Patients PHASE3 End-stage liver disease due to hepatitis C virus (HCV) is the most common i...
Show More Location
123, Ta Pei Road, Niao Sung Hsiang
Learn More & Join Trial
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PHASE2 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C PHASE3 This study is to evaluate the overall efficacy, and safety profile of the t...
Show More Location
Novartis Investigative Site
Learn More & Join Trial